13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0000902664-25-000931
Total Value
$101.9M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,664,548 | $70.1M | 68.79% |
| 2 | TG THERAPEUTICS INC | TGTX | 161,600 | $4.9M | 4.78% |
| 3 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $4.8M | 4.76% |
| 4 | INVIVYD INC | IVVD | 9,248,250 | $4.1M | 4.02% |
| 5 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 110,400 | $4.0M | 3.92% |
| 6 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $3.8M | 3.75% |
| 7 | BRIDGEBIO PHARMA INC | BBIO | 121,200 | $3.3M | 3.27% |
| 8 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $2.7M | 2.65% |
| 9 | CURIS INC | CRIS | 521,059 | $1.6M | 1.57% |
| 10 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $1.3M | 1.25% |
| 11 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $1.3M | 1.24% |